A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT04029909 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Epithelial Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer

Interventions

DRUG: Gimatecan 0.6mg/m2/d
DRUG: 0.8mg/m2/d
DRUG: 0.4mg/m2/d

Sponsor

Lee's Pharmaceutical Limited